Skip to main content

Research Repository

Advanced Search

Randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo: results of the HI‐Light Vitiligo trial

Thomas, K.S.; Batchelor, J. M.; Akram, P.; Chalmers, J. R.; Haines, RH; Meakin, G. D.; Duley, L.; Ravenscroft, J. C.; Rogers, A.; Sach, T. H.; Santer, M.; Tan, W.; White, J.; Whitton, M. E.; Williams, H. C.; Cheung, S. T.; Hamad, H.; Wright, A.; Ingram, J. R.; Levell, N. J.; Goulding, J. M. R.; Makrygeorgou, A.; Bewley, A.; Ogboli, M.; Stainforth, J.; Ferguson, A.; Laguda, B.; Wahie, S.; Ellis, R.; Azad, J.; Rajasekaran, A.; Eleftheriadou, V.; Montgomery, A. A.

Randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo: results of the HI‐Light Vitiligo trial Thumbnail


Authors

J. M. Batchelor

P. Akram

J. R. Chalmers

RH Haines

GARRY MEAKIN Garry.Meakin@nottingham.ac.uk
Senior Trial Manager

L. Duley

J. C. Ravenscroft

A. Rogers

T. H. Sach

M. Santer

W. Tan

M. E. Whitton

Profile image of HYWEL WILLIAMS

HYWEL WILLIAMS HYWEL.WILLIAMS@NOTTINGHAM.AC.UK
Professor of Dermato-Epidemiology

S. T. Cheung

H. Hamad

A. Wright

J. R. Ingram

N. J. Levell

J. M. R. Goulding

A. Makrygeorgou

A. Bewley

M. Ogboli

J. Stainforth

A. Ferguson

B. Laguda

S. Wahie

R. Ellis

J. Azad

A. Rajasekaran

V. Eleftheriadou

ALAN MONTGOMERY ALAN.MONTGOMERY@NOTTINGHAM.AC.UK
Director Nottingham Clinical Trials Unit



Abstract

Background
Evidence for the effectiveness of vitiligo treatments is limited.

Objectives
To determine effectiveness of (a) hand‐held narrowband‐UVB (NB‐UVB) and (b) combination of potent topical corticosteroid (TCS) and NB‐UVB compared to TCS, for localised vitiligo.

Methods
Pragmatic, 3‐arm, placebo‐controlled RCT (9 months’ treatment; 12 months’ follow‐up). Adults and children, recruited from secondary care and community, aged ≥5 years with active vitiligo affecting 75% expected were more likely to achieve treatment success, but effects were lost once treatment stopped. Localised grade 3 or 4 erythema was reported in 62 (12%) participants (including 3 with dummy light). Skin thinning was reported in 13 (2.5%) participants (including 1 with placebo ointment).

Conclusion
Combination treatment with home‐based hand‐held NB‐UVB plus TCS is likely to be superior to TCS alone for treatment of localised vitiligo. Combination treatment was relatively safe and well tolerated but was only successful in around a quarter of participants.

Citation

Thomas, K., Batchelor, J. M., Akram, P., Chalmers, J. R., Haines, R., Meakin, G. D., …Montgomery, A. A. (2021). Randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo: results of the HI‐Light Vitiligo trial. British Journal of Dermatology, 184(5), 828-839. https://doi.org/10.1111/bjd.19592

Journal Article Type Article
Acceptance Date Sep 29, 2020
Online Publication Date Oct 2, 2020
Publication Date 2021-05
Deposit Date Oct 12, 2020
Publicly Available Date Oct 3, 2021
Journal British Journal of Dermatology
Print ISSN 0007-0963
Electronic ISSN 1365-2133
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 184
Issue 5
Pages 828-839
DOI https://doi.org/10.1111/bjd.19592
Keywords Dermatology
Public URL https://nottingham-repository.worktribe.com/output/4959896
Publisher URL https://onlinelibrary.wiley.com/doi/10.1111/bjd.19592

Files





You might also like



Downloadable Citations